EA201070295A1 - Лечение рака легких - Google Patents

Лечение рака легких

Info

Publication number
EA201070295A1
EA201070295A1 EA201070295A EA201070295A EA201070295A1 EA 201070295 A1 EA201070295 A1 EA 201070295A1 EA 201070295 A EA201070295 A EA 201070295A EA 201070295 A EA201070295 A EA 201070295A EA 201070295 A1 EA201070295 A1 EA 201070295A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lung cancer
treatment
inhibit
treat
subject
Prior art date
Application number
EA201070295A
Other languages
English (en)
Russian (ru)
Inventor
Синтия В. Татхилл
Original Assignee
Сиклоун Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сиклоун Фармасьютикалз, Инк. filed Critical Сиклоун Фармасьютикалз, Инк.
Publication of EA201070295A1 publication Critical patent/EA201070295A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
EA201070295A 2007-08-23 2008-08-21 Лечение рака легких EA201070295A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95753007P 2007-08-23 2007-08-23
PCT/US2008/009932 WO2009025830A1 (en) 2007-08-23 2008-08-21 Treatment of lung cancer

Publications (1)

Publication Number Publication Date
EA201070295A1 true EA201070295A1 (ru) 2010-10-29

Family

ID=40378469

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070295A EA201070295A1 (ru) 2007-08-23 2008-08-21 Лечение рака легких

Country Status (14)

Country Link
US (1) US20110189305A1 (cg-RX-API-DMAC7.html)
EP (1) EP2192835A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010536854A (cg-RX-API-DMAC7.html)
KR (1) KR20100063078A (cg-RX-API-DMAC7.html)
CN (1) CN101842009A (cg-RX-API-DMAC7.html)
AU (1) AU2008289522A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0815772A2 (cg-RX-API-DMAC7.html)
CA (1) CA2697261A1 (cg-RX-API-DMAC7.html)
EA (1) EA201070295A1 (cg-RX-API-DMAC7.html)
MX (1) MX2010002046A (cg-RX-API-DMAC7.html)
NZ (1) NZ584065A (cg-RX-API-DMAC7.html)
UA (1) UA98508C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009025830A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201001876B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090119897A (ko) 2007-02-13 2009-11-20 사이클론 파아머슈티컬 인코오퍼레이티드 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법
RU2519738C2 (ru) * 2011-12-12 2014-06-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации Способ лечения рака легкого

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких

Also Published As

Publication number Publication date
UA98508C2 (ru) 2012-05-25
EP2192835A1 (en) 2010-06-09
ZA201001876B (en) 2010-11-24
NZ584065A (en) 2012-03-30
JP2010536854A (ja) 2010-12-02
WO2009025830A1 (en) 2009-02-26
US20110189305A1 (en) 2011-08-04
MX2010002046A (es) 2010-05-03
CA2697261A1 (en) 2009-02-26
CN101842009A (zh) 2010-09-22
AU2008289522A1 (en) 2009-02-26
BRPI0815772A2 (pt) 2014-09-30
KR20100063078A (ko) 2010-06-10
EP2192835A4 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
EA201170521A1 (ru) Новые соединения
EA201270247A1 (ru) Способы применения с-мет-модуляторов
EA201171367A1 (ru) Винилиндазолильные соединения
TN2009000400A1 (en) Methods of treating cancer using pyridopyrimidininone inhibitors of pi3k alpha
EP2294184A4 (en) TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY
UA98141C2 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201300860A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
CA2909625C (en) Combination therapy comprising a tor kinase inhibitor and a 5-substituted quinazolinone compound for treating cancer
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
EA201170832A1 (ru) Пуриновые соединения
PA8850801A1 (es) Compuestos útiles para inhibir chk1
EA201491694A1 (ru) Лечение рака ингибиторами tor киназы
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
BRPI0908635A8 (pt) composto, composição farmacêutica e método de tratamento de câncer
PH12015501088A1 (en) Dimeric compounds
UA114417C2 (uk) Інгібітори iap
EA200900691A1 (ru) Применение ингибиторов iap для лечения острого миелоидного лейкоза
JO3145B1 (ar) مركبات مفيدة لتثبيط chk1
EA201490199A1 (ru) Терапевтические способы
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.